The solo practice premium: why independents are worth more per chair

private equity firms are paying 9x EBITDA for group practices. That same metric for independent dental practices is 11x to 13x. Why are they paying 20 to 40 percent more for the thing they're supposed to consolidate?

Two reasons. First, an independent practice runs at 35 to 42 percent EBITDA margins because the doctor owns it and cares about profit. A group practice runs 22 to 28 percent because every location is staffed for scaling, not optimization. The independent practice's profit is real. The group practice's profit is a story told in forecasts.

Second, when PE acquires an independent, they inherit a doctor-owner who stays. When they acquire a group, they inherit a CEO who leaves in 18 months and takes key relationships with them. The independent solo practitioner is the asset. The group is a revenue machine with management risk.

This tells you something important: if you're running solo and your practice is profitable, you're sitting on serious valuation. If you're thinking about selling, don't get distracted by DSO roll-up offers at 6x. The market will pay more if the numbers are clean. Document everything. Get a broker. The premium for independence is real and growing.

For the DSO inside a group: You're optimizing the wrong thing. You're competing for consolidation margin, not for ownership value.

OPERATOR MATH

Let's compare the valuation math for independent versus group practices and calculate the independence premium in dollar terms. Start with a solo independent practice: $950,000 annual revenue, 38% EBITDA ($361,000). PE firms pay 11-13x EBITDA for clean, owner-operated independents with strong patient retention. At 12x EBITDA, valuation: $4.332 million. The practice is also valued at 4.0-4.5x revenue for independents with high margins. At 4.3x revenue: $4.085 million. Average of both methods: $4.2 million sale price.

Now compare to a group practice (5 locations): $4.5 million annual revenue, 25% EBITDA ($1.125 million). Group practices trade at 9-10x EBITDA because they carry management risk, operational complexity, and lower margins (staffed for scale, not profit). At 9.5x EBITDA: $10.688 million. Revenue multiple for groups: 3.2-3.6x. At 3.4x revenue: $15.3 million. Average: $13 million sale price. Per-location value: $2.6 million ($13M / 5 locations).

The delta: independent solo sells for $4.2 million. Group location sells for $2.6 million. The independence premium: $1.6 million per location, or 62% higher valuation. Why? The independent has 38% EBITDA; the group location averages 25%. The independent's profit is $361,000 on $950,000 revenue. The group location's allocated profit is $225,000 on $900,000 revenue (assuming equal revenue distribution across 5 locations). Higher profit commands higher multiples. The independent also has lower management risk (owner stays post-acquisition) and simpler integration (one location, one culture, one PMS).

Now model the optimization impact. If the solo owner tightens operations over 90 days and lifts EBITDA from 38% to 42% (achievable via scheduling optimization, supplier renegotiation, and collections improvement), EBITDA jumps to $399,000. At 12x EBITDA: $4.788 million. At 4.5x revenue (premium multiple for 40%+ margin practices): $4.275 million. Average: $4.53 million. The practice owner just added $330,000 to exit value by improving EBITDA 4 points. That's the leverage of margin optimization at exit. Every point of EBITDA you add multiplies your exit price by 10-13x. Groups can't move the margin needle as easily (they're optimizing five locations, not one). Independents can tighten operations in 60-90 days and capture the valuation premium immediately.

THE TAKEAWAY

If you're an independent practice owner considering a sale in the next 2-3 years, focus on margin optimization starting this quarter. Pull your financials and calculate your actual EBITDA margin (net income before interest, taxes, depreciation, and amortization, divided by revenue). If you're under 35%, you're leaving 15-25% on the table at exit. Identify your three biggest cost leaks: typically labor inefficiency (overstaffed or underproductive hours), supplier costs (paying retail or locked into bad contracts), and collections (AR over 60 days eating working capital).

Fix those three over the next 90 days. Tighten scheduling to reduce gaps and boost doctor productivity. Renegotiate your top five supplier contracts or switch vendors. Push collections on AR over 60 days and get it under 10% of total receivables. Every point of EBITDA improvement adds 10-13x to your exit valuation. A 4-point lift (from 35% to 39%) on a $900,000 practice adds $360,000-$468,000 to your sale price. That's worth three months of focused work.

Then get a professional valuation from a firm specializing in dental M&A (not your broker's estimate). Understand your baseline value and what levers move it most (EBITDA margin, patient retention, payer mix diversification). When you're ready to sell, interview at least three buyers: a DSO, a PE-backed platform, and a private buyer. The valuation spread will be significant (often 20-40%). Independents with strong margins and low management risk command premium multiples. Position yourself there, and you'll capture $500K-$1.5M more at exit than an unoptimized practice. The independence premium is real. Earn it by running a tight operation, then sell at the top of the market.